Clinical Trials · NCT07814651
A Clinical Trial to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Octreotide Long-acting Injection in Patients With Acromegaly
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Enrollment
- 78
- Start date
- Apr 2024
- Locations
- 1 site, China
- Primary endpoint
- The proportion of patients with an IGF-1 index ≤ 1.0